Bridgefront Capital’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Sell
5,196
-12,623
-71% -$589K 0.08% 371
2026
Q1
$644K Buy
+17,819
New +$745K 0.16% 211
2025
Q2
– Sell
-11,612
Closed -$485K – 622
2025
Q1
$485K Buy
+11,612
New +$604K 0.14% 264
2023
Q3
– Sell
-4,555
Closed -$337K – 408
2023
Q2
$337K Sell
4,555
-527
-10% -$40.2K 0.18% 216
2023
Q1
$401K Buy
+5,082
New +$367K 0.24% 148
2021
Q2
– Sell
-8,121
Closed -$522K – 622
2021
Q1
$522K Buy
+8,121
New +$488K 0.16% 217

Other funds holding BRKR

Bridgefront Capital's BRKR Position: Q2 2026 in Review

Bridgefront Capital reduced its Bruker (BRKR) stake by 71% in Q2 2026, selling an estimated $589K and leaving 5,196 shares worth $313K. The position accounts for 0.08% of the portfolio, ranked #371.

Bridgefront Capital first reported a position in BRKR in Q1 2021 and has held it in 6 quarters since. The position peaked at $644K in Q1 2026. 417 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Bridgefront Capital held 5,196 shares of Bruker worth $313K as of Q2 2026.
  • Bridgefront Capital sold 12,623 Bruker shares in Q2 2026, an estimated $589K.
  • Bruker made up 0.08% of Bridgefront Capital's portfolio in Q2 2026, its #371 holding.
  • Bridgefront Capital first reported a position in Bruker in Q1 2021 and has held it in 6 quarters since.
  • Bridgefront Capital's Bruker position peaked at $644K in Q1 2026.
  • 417 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.